MIS2020 Recap: Session 4

MIS2020 Recap: Session 4

Whether you joined us live on October 6, watched content On Demand, or have yet to engage with the 2020 Medical Innovation Summit by Cleveland Clinic, the learning opportunity remains as we continue to host recordings of the live event on our interactive platform. Access to these recordings, however, expires 12/31 – sign in or register today to view them before they’re gone! With this, our last session recap of MIS2020, be sure to read in full and check out the rest of the blog for additional Summit content. Don’t miss your chance to relive the most influential healthcare conference of the year.

MIS2020 Session 4: 
Fireside Chat: Safra Catz, Business Brief: David Fredrickson, Top 10: 2021

In this last session of MIS2020, our attendees had the benefit of tailored insights from absolute experts in their respective fields. Be it information technology, the pharmaceutical industry, or delivery of enhanced patient care, session 4’s lineup drove the concept of informed thought leadership. This conglomerate of firesides, keynotes, and panels closed an exceptional day of content, driving our audience toward further health innovation with messages of cooperation, creativity, compassion, and hope.  

Speaking with Cleveland Clinic’s Chief Financial Officer, Steve Glass, Oracle CEO Safra Catz shared her knowledge of the digital space in an increasingly connected time for healthcare. With distance health initiatives on the rise, research stakes higher than they’ve ever been, and protocol adherence of the utmost importance, the need for effective data management and cloud computing abilities cannot be understated. Catz spoke candidly about her desire to increase health systems’ abilities to draw insights from large amounts of data and ensure storage space for everything from staffing and payroll to ground-breaking COVID-19 research. Investing billions into the underlying technology to keep systems secure, Catz and her team are making contributions to healthcare the best way they know how. 

For David Fredrickson, EVP, Oncology Business Unit, AstraZeneca, data was also a concern – though it was the data that concerned him. Citing that new cancer patients identified had fallen by nearly 50% across six cancer types in the U.S. and may lead to up to 10,000 deaths in the next decade, Fredrickson preached the withstanding importance of preventative screening. Detailing some of AstraZeneca’s initiatives to keep cancer care a priority in COVID-19, his business brief served as a harrowing reminder that healthcare is not on hold. 

To cap the 2020 Medical Innovation Summit, we revealed numbers one through three on our Top 10 Medical Innovations list for 2021. Bringing focus back to the patient before the event’s close, the Top 10 delivered on its promise – informing and inspiring professionals from all domains to advance practices everywhere. Sharing their experience with our top three innovations – ‘Smartphone-Connected Pacemaker Devices,’ ‘Novel Drug for Primary-Progressive Multiple Sclerosis,’ and ‘Gene Therapy for Hemoglobinopathies’ – experts Khaldoun Tarakji, MD, Adrienne Boissy, MD, and Rabi Hanna, MD shed light on the importance of these advances.  
In addition to the live content presented on October 6, the Summit offered several pre-recorded sessions for concepts we simply couldn’t leave off the agenda. With topics like precision medicine and our institution’s united response to the COVID-19 pandemic, these panels served to strengthen our conference offerings and keep the conversation lively before and after the live stream. 

Albeit virtual, MIS2020 was truly one of our best. The shared passion for innovation through adversity has brought a spark of hope to these dark times – a spark we will continue to fan into flames on behalf of the health ecosystem. For true insight and in-depth discussions of the above concepts, view the fourth session of MIS2020, its preceding sessions, and all pre-recorded content anytime through December 31. Log in or register in the next two weeks to gain access, and let us know what you think through this short survey

Get In Touch With Us